Healthcare ❯Pharmaceuticals
Mental Health Multiple Sclerosis Treatments Industry Analysis Biopharmaceuticals Drug Development Vaccines Combination Treatments Clinical Trials
The acquisition strengthens J&J's focus on neuroscience and expands its portfolio with Caplyta and a promising drug pipeline.
